166 related articles for article (PubMed ID: 3276544)
41. Combination of magnetic and chemocytotoxic cancer cell depletion for autologous bone marrow transplantation.
Morecki S; Slavin S
Isr J Med Sci; 1988; 24(9-10):488-93. PubMed ID: 3060442
[TBL] [Abstract][Full Text] [Related]
42. Successful purging of murine plasmacytoma by mafosfamide (ASTA-Z).
Weiss L; Slavin G; Reich S; Sidi H; Slavin S
Bone Marrow Transplant; 1994 Jan; 13(1):27-30. PubMed ID: 8019450
[TBL] [Abstract][Full Text] [Related]
43. Limiting dilution analysis for detection of residual leukemic cells after bone marrow combined decontamination with mafosfamide followed by merocyanine-540-mediated photosensitization.
Porcellini A; Rossi MT; Manna A; Sparaventi G; Pazzaglia C
Int J Cell Cloning; 1989 Jul; 7(4):223-31. PubMed ID: 2671163
[TBL] [Abstract][Full Text] [Related]
44. Normal blast colony formation: an in vitro tool for monitoring human bone marrow 'purging'.
Degliantoni G; Mangoni L; Rizzoli V
Bone Marrow Transplant; 1986 Dec; 1(2):209-13. PubMed ID: 3332133
[TBL] [Abstract][Full Text] [Related]
45. Autologous bone marrow transplantation using marrow incubated with Asta Z 7557 in adult acute leukemia.
Gorin NC; Douay L; Laporte JP; Lopez M; Mary JY; Najman A; Salmon C; Aegerter P; Stachowiak J; David R
Blood; 1986 May; 67(5):1367-76. PubMed ID: 3516254
[TBL] [Abstract][Full Text] [Related]
46. Purging of G-CSF-mobilized peripheral autografts in acute leukemia with mafosfamide and amifostine to protect normal progenitor cells.
Fauth F; Martin H; Sonnhoff S; Bialleck H; Wiesneth M; Mihanovic B; Hoelzer D
Bone Marrow Transplant; 2000 Apr; 25(8):831-6. PubMed ID: 10808203
[TBL] [Abstract][Full Text] [Related]
47. Assessment of purging with multidrug resistance (MDR) modulators and VP-16: results of long-term marrow culture.
Aihara M; Sikic BI; Blume KG; Chao NJ
Exp Hematol; 1990 Sep; 18(8):940-4. PubMed ID: 2387345
[TBL] [Abstract][Full Text] [Related]
48. In vitro sensitivity of human hematopoietic progenitor cells to 4-hydroperoxycyclophosphamide.
Ratajczak MZ; Ratajczak J; Kuczynski W; Light B; Lusk EJ; Gewirtz AM
Exp Hematol; 1993 Dec; 21(13):1663-7. PubMed ID: 8243568
[TBL] [Abstract][Full Text] [Related]
49. Autologous bone marrow transplantation for acute leukemia using transplant chemopurified with metabolite of oxazaphosphorines (ASTA Z 7557, INN mafosfamide). First clinical results.
Hervé P; Cahn JY; Plouvier E; Flesch M; Tamayo E; Leconte des Floris R; Peters A
Invest New Drugs; 1984; 2(2):245-52. PubMed ID: 6381384
[TBL] [Abstract][Full Text] [Related]
50. Dose-dependent effect of etoposide in combination with busulfan plus cyclophosphamide as conditioning for stem cell transplantation in patients with acute myeloid leukemia.
Kröger N; Zabelina T; Sonnenberg S; Krüger W; Renges H; Stute N; Finkenstein F; Mayer U; Holstein K; Fiedler W; Colberg H; Sonnen R; Kuse R; Braumann D; Metzner B; del Valle F; Erttmann R; Kabisch H; Zander AR
Bone Marrow Transplant; 2000 Oct; 26(7):711-6. PubMed ID: 11042650
[TBL] [Abstract][Full Text] [Related]
51. Amifostine improves the antileukemic therapeutic index of mafosfamide: implications for bone marrow purging.
Douay L; Hu C; Giarratana MC; Bouchet S; Conlon J; Capizzi RL; Gorin NC
Blood; 1995 Oct; 86(7):2849-55. PubMed ID: 7670119
[TBL] [Abstract][Full Text] [Related]
52. Protection of bone marrow stromal cells from the toxic effects of cyclophosphamide in vivo and of ASTA-Z 7557 and etoposide in vitro by ammonium trichloro(dioxyethylene-O-O')tellurate (AS101).
Kalechman Y; Sotnik-Barkai I; Albeck M; Sredni B
Cancer Res; 1993 Apr; 53(8):1838-44. PubMed ID: 8467503
[TBL] [Abstract][Full Text] [Related]
53. Correlation of colony-forming cells, long-term culture initiating cells and CD34+ cells in apheresis products from patients mobilized for peripheral blood progenitors with different regimens.
Bender JG; Lum L; Unverzagt KL; Lee W; Van Epps D; George S; Coon J; Ghalie R; McLeod B; Kaizer H
Bone Marrow Transplant; 1994 Apr; 13(4):479-85. PubMed ID: 7517260
[TBL] [Abstract][Full Text] [Related]
54. Sensitivity of human CFU-GM to mafosfamide: analysis of the factors affecting individual variations.
Domenech J; Desbois I; Linassier C; Gihana E; Chenault S; Brémond JL; Colombat P; Lamagnère JP; Binet C
Bone Marrow Transplant; 1993 Jun; 11(6):425-31. PubMed ID: 8334422
[TBL] [Abstract][Full Text] [Related]
55. Potential drugs for elimination of acute lymphatic leukemia cells from autologous bone marrow.
Blaauw A; Spitzer G; Dicke K; Drewinko B; Vellekoop L; Zander A
Exp Hematol; 1986 Aug; 14(7):683-8. PubMed ID: 2426131
[TBL] [Abstract][Full Text] [Related]
56. In vitro chemoseparation of leukemic cells from murine bone marrow using VP16-213: importance of stem cell assays.
Stiff PJ; Koester AR
Exp Hematol; 1987 Mar; 15(3):263-8. PubMed ID: 3545881
[TBL] [Abstract][Full Text] [Related]
57. Comparative effects of ASTA Z 7557 (INN mafosfamide) and cyclophosphamide on hematopoiesis in mice.
Nowrousian MR; Schmidt CG
Invest New Drugs; 1984; 2(2):207-13. PubMed ID: 6469516
[TBL] [Abstract][Full Text] [Related]
58. Peripheral blood progenitor cell transplantation: a single centre experience comparing two mobilisation regimens in 67 patients.
Mahendra P; Johnson D; Scott MA; Jestice HK; Hood IM; Ager S; Bass G; Barker P; Boraks PA; Bloxham DM; Baglin TP; Marcus RE
Bone Marrow Transplant; 1996 Apr; 17(4):503-7. PubMed ID: 8722346
[TBL] [Abstract][Full Text] [Related]
59. Cumulative chemotherapy increases mafosfamide toxicity for normal progenitor cells in AML patients: rationale for cryopreserving adapted-dose purged marrow early in first complete remission.
Martin H; Bruecher J; Claudé R; Hoelzer D
Bone Marrow Transplant; 1993 Nov; 12(5):495-9. PubMed ID: 8298560
[TBL] [Abstract][Full Text] [Related]
60. Recovery of the ability to induce immune resistance against L1210 lymphatic leukemia in semisyngeneic CD2F1 mice after lethal irradiation and reconstitution with bone marrow purged of leukemia with mafosfamide (ASTA Z 7654).
Skórski T; Kawalec M
Bone Marrow Transplant; 1987 Dec; 2(4):435-40. PubMed ID: 3332191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]